Belgium Data Desk › Health › Real-world evidence of Entresto adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction

Real-world evidence of Entresto adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction

Name: Real-world evidence of Entresto adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction
Creator: Novartis
License: https://opendatacommons.org/licenses/by/1-0/

Novartis and RIZIV-INAMI agreed upon an article 81 procedure for which real world evidence of Entresto needs to be collected in order to evaluate the product for future reimbursement. Reimbursement criteria for Entresto are defined by the Royal Decree of Dec. 21 2001 §8410000. Entresto is reimbursed starting from Nov.

Publisher: Novartis
Licence: ODC-BY
Open licence — reuse allowed, usually with attribution
Topic: Health
Type: Dataset
Last updated (catalogue): 2026-08-11
Formats: XLSX, CSV, JSON
Contact: trialandresults.registries@novartis.com

Open in Belgium Data DeskPreview, profile and run SQL in your browser

Official page at the publisher ↗

Download link checked on 2026-10-04: 3 of 3 worked. This page describes catalogue information. It does not state that the data is correct.

Real-world evidence of Entresto adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction

More in this topic